Michael S. Leibowitz

1.7k total citations
14 papers, 505 citations indexed

About

Michael S. Leibowitz is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Michael S. Leibowitz has authored 14 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Michael S. Leibowitz's work include Immunotherapy and Immune Responses (5 papers), Peptidase Inhibition and Analysis (3 papers) and Immune Cell Function and Interaction (3 papers). Michael S. Leibowitz is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Peptidase Inhibition and Analysis (3 papers) and Immune Cell Function and Interaction (3 papers). Michael S. Leibowitz collaborates with scholars based in United States, Slovakia and Russia. Michael S. Leibowitz's co-authors include Robert L. Ferris, Soldano Ferrone, Pedro A. Andrade Filho, Steven Μ. Albelda, Robert H. Vonderheide, Adam C. Henry, Tomoyuki Tanaka, Richard G. Carroll, Daniel H. Sterman and Peter DeLong and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Michael S. Leibowitz

14 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael S. Leibowitz United States	10	315	262	166	106	40	14	505
Nancy P. Judd United States	7	275 0.9×	262 1.0×	183 1.1×	66 0.6×	64 1.6×	7	544
Lillian Sun United States	7	378 1.2×	298 1.1×	120 0.7×	63 0.6×	36 0.9×	9	508
Ravindra Uppaluri United States	10	313 1.0×	390 1.5×	159 1.0×	44 0.4×	62 1.6×	25	590
Houssein Abdul Sater United States	11	373 1.2×	298 1.1×	122 0.7×	81 0.8×	41 1.0×	33	513
Yasuhiro Terazaki Japan	12	191 0.6×	105 0.4×	182 1.1×	112 1.1×	44 1.1×	21	425
Haejung Won United States	10	293 0.9×	311 1.2×	213 1.3×	90 0.8×	78 1.9×	12	563
Sheryl Kunning United States	7	344 1.1×	305 1.2×	108 0.7×	71 0.7×	57 1.4×	10	503
Sarah Greene United States	5	370 1.2×	393 1.5×	81 0.5×	40 0.4×	36 0.9×	5	516
George Locke United States	6	336 1.1×	187 0.7×	239 1.4×	69 0.7×	44 1.1×	9	540
Alexandro Landshammer Germany	6	322 1.0×	229 0.9×	122 0.7×	81 0.8×	44 1.1×	8	476

Countries citing papers authored by Michael S. Leibowitz

Since Specialization

Citations

This map shows the geographic impact of Michael S. Leibowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Leibowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Leibowitz more than expected).

Fields of papers citing papers by Michael S. Leibowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Leibowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Leibowitz. The network helps show where Michael S. Leibowitz may publish in the future.

Co-authorship network of co-authors of Michael S. Leibowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. Leibowitz. A scholar is included among the top collaborators of Michael S. Leibowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. Leibowitz. Michael S. Leibowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Lin, Shuibin, Lily L. Nguyen, Alexandra McMellen, et al.. (2024). Leveraging Multi-omics to Disentangle the Complexity of Ovarian Cancer. Molecular Diagnosis & Therapy. 29(2). 145–151. 1 indexed citations

Klampatsa, Astero, Michael S. Leibowitz, Jing Sun, et al.. (2020). Analysis and Augmentation of the Immunologic Bystander Effects of CAR T Cell Therapy in a Syngeneic Mouse Cancer Model. Molecular Therapy — Oncolytics. 18. 360–371. 38 indexed citations

Rabe, Jennifer L., Christy M. Gearheart, Michael S. Leibowitz, et al.. (2019). IL12 Abrogates Calcineurin-Dependent Immune Evasion during Leukemia Progression. Cancer Research. 79(14). 3702–3713. 6 indexed citations

Kimura, Tōru, James Monslow, Astero Klampatsa, et al.. (2019). Loss of cells expressing fibroblast activation protein has variable effects in models of TGF-β and chronic bleomycin-induced fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 317(2). L271–L282. 25 indexed citations

Leibowitz, Michael S., et al.. (2018). Standardization of prophylactic platelet transfusion dosing in a pediatric oncology population: a quality improvement project. Transfusion. 58(12). 2836–2840. 4 indexed citations

Leibowitz, Michael S., Rahul Srivastava, Pedro A. Andrade Filho, et al.. (2013). SHP2 Is Overexpressed and Inhibits pSTAT1-Mediated APM Component Expression, T-cell Attracting Chemokine Secretion, and CTL Recognition in Head and Neck Cancer Cells. Clinical Cancer Research. 19(4). 798–808. 63 indexed citations

Leibowitz, Michael S., Pedro A. Andrade Filho, Soldano Ferrone, & Robert L. Ferris. (2011). Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes. Cancer Immunology Immunotherapy. 60(4). 525–535. 84 indexed citations

Leibowitz, Michael S., et al.. (2009). Immunotherapy for head and neck cancer. Oral Oncology. 45(9). 747–751. 8 indexed citations

Leibowitz, Michael S., Jayakar V. Nayak, & Robert L. Ferris. (2008). Head and neck cancer immunotherapy: Clinical evaluation. Current Oncology Reports. 10(2). 162–169. 15 indexed citations

10.

Sen, Malabika, Michael J. Ryan, Jerry D. Johnson, et al.. (2008). Lack of toxicity of a STAT3 decoy oligonucleotide. Cancer Chemotherapy and Pharmacology. 63(6). 983–995. 39 indexed citations

11.

Wesa, Amy, Maja Mandić, Jennifer Taylor, et al.. (2008). Enhancement in Specific CD8+ T Cell Recognition of EphA2+ Tumors In Vitro and In Vivo after Treatment with Ligand Agonists. The Journal of Immunology. 181(11). 7721–7727. 24 indexed citations

12.

Domchek, Susan M., Adri Recio, Rosemarie Mick, et al.. (2007). Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance. Cancer Research. 67(21). 10546–10555. 75 indexed citations

13.

Couch, Marion E., Robert L. Ferris, Joseph Brennan, et al.. (2007). Alteration of Cellular and Humoral Immunity by Mutant p53 Protein and Processed Mutant Peptide in Head and Neck Cancer. Clinical Cancer Research. 13(23). 7199–7206. 24 indexed citations

14.

DeLong, Peter, Richard G. Carroll, Adam C. Henry, et al.. (2005). Regulatory T cells and cytokines in malignant pleural effusions secondary to mesothelioma and carcinoma. Cancer Biology & Therapy. 4(3). 342–346. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact